Advertisement
Editorial

The Unfinished Public Health Agenda of Chagas Disease in the Era of Globalization

  • Carlos Franco-Paredes mail,

    cfranco@sph.emory.edu

    Affiliations: Hospital Infantil de México, Federico Gómez, México, D.F., México, Department of Medicine, Emory University, Atlanta, Georgia, United States of America

    X
  • Maria Elena Bottazzi,

    Affiliations: Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, D.C., United States of America, Sabin Vaccine Institute, Washington, D.C., United States of America

    X
  • Peter J. Hotez

    Affiliations: Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, D.C., United States of America, Sabin Vaccine Institute, Washington, D.C., United States of America

    X
  • Published: July 07, 2009
  • DOI: 10.1371/journal.pntd.0000470

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients

Isabela Ribeiro, Ann-Marie Sevcsik, Fabiana Alves, Graciela Diap, Robert Don, Michael O. Harhay, Shing Chang, Bernard Pecoul
Policy Platform | published 7 Jul 2009 | PLOS Neglected Tropical Diseases
doi:10.1371/journal.pntd.0000484

Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières

Oliver Yun, M. Angeles Lima, Tom Ellman, Wilma Chambi, Sandra Castillo, Laurence Flevaud, Paul Roddy, Fernando Parreño, Pedro Albajar Viñas, Pedro Pablo Palma
Research Article | published 7 Jul 2009 | PLOS Neglected Tropical Diseases
doi:10.1371/journal.pntd.0000488